Daiichi Sankyo Company, Limited (DSKYF)
USD 26.5
(0.0%)
USD 26.5
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 211.58 Billion JPY | 73.69% |
| 2023 | 121.81 Billion JPY | 47.73% |
| 2022 | 82.46 Billion JPY | 2.85% |
| 2021 | 80.17 Billion JPY | -32.07% |
| 2020 | 118.02 Billion JPY | 30.47% |
| 2019 | 90.46 Billion JPY | -19.47% |
| 2018 | 112.32 Billion JPY | -12.16% |
| 2017 | 127.87 Billion JPY | -16.99% |
| 2016 | 154.05 Billion JPY | 107.0% |
| 2015 | 74.42 Billion JPY | -34.09% |
| 2014 | 112.92 Billion JPY | 14.36% |
| 2013 | 98.74 Billion JPY | 0.55% |
| 2012 | 98.2 Billion JPY | -19.6% |
| 2011 | 122.14 Billion JPY | 27.89% |
| 2010 | 95.5 Billion JPY | 7.47% |
| 2009 | 88.87 Billion JPY | -43.33% |
| 2008 | 156.82 Billion JPY | 15.05% |
| 2007 | 136.31 Billion JPY | -11.9% |
| 2006 | 154.72 Billion JPY | 82.19% |
| 2005 | 84.92 Billion JPY | -11.12% |
| 2004 | 95.55 Billion JPY | 19.69% |
| 2003 | 79.83 Billion JPY | -1.01% |
| 2002 | 80.64 Billion JPY | -8.13% |
| 2001 | 87.78 Billion JPY | -38.48% |
| 2000 | 142.71 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 43.42 Billion JPY | 350.42% |
| 2024 FY | 186.01 Billion JPY | 52.7% |
| 2024 Q3 | 73.28 Billion JPY | 44.26% |
| 2024 Q4 | 16.69 Billion JPY | -77.22% |
| 2024 Q2 | 50.79 Billion JPY | 16.97% |
| 2023 Q4 | -17.34 Billion JPY | -154.55% |
| 2023 FY | 121.81 Billion JPY | 47.73% |
| 2023 Q3 | 31.79 Billion JPY | -40.58% |
| 2023 Q2 | 53.5 Billion JPY | 56.37% |
| 2023 Q1 | 34.21 Billion JPY | 167.42% |
| 2022 Q2 | 38.97 Billion JPY | -14.85% |
| 2022 Q1 | 45.77 Billion JPY | 278.32% |
| 2022 Q4 | -50.74 Billion JPY | -230.02% |
| 2022 FY | 82.46 Billion JPY | 2.85% |
| 2022 Q3 | 39.03 Billion JPY | 0.15% |
| 2021 Q1 | 34.12 Billion JPY | 303.34% |
| 2021 Q2 | 24.34 Billion JPY | -28.66% |
| 2021 Q3 | 30.99 Billion JPY | 27.33% |
| 2021 Q4 | -25.66 Billion JPY | -182.81% |
| 2021 FY | 80.17 Billion JPY | -32.07% |
| 2020 Q3 | 69.41 Billion JPY | 137.98% |
| 2020 Q2 | 29.17 Billion JPY | -48.82% |
| 2020 Q1 | 56.99 Billion JPY | 526.05% |
| 2020 FY | 118.02 Billion JPY | 30.47% |
| 2020 Q4 | -16.78 Billion JPY | -124.17% |
| 2019 Q4 | -13.37 Billion JPY | -134.21% |
| 2019 Q3 | 39.09 Billion JPY | 39.31% |
| 2019 Q2 | 28.06 Billion JPY | -6.19% |
| 2019 FY | 90.46 Billion JPY | -19.47% |
| 2019 Q1 | 29.91 Billion JPY | 276.57% |
| 2018 Q2 | 8.48 Billion JPY | -78.93% |
| 2018 Q4 | -16.94 Billion JPY | -138.1% |
| 2018 Q3 | 44.46 Billion JPY | 424.07% |
| 2018 FY | 112.32 Billion JPY | -12.16% |
| 2018 Q1 | 40.27 Billion JPY | 201.24% |
| 2017 Q4 | -39.77 Billion JPY | -171.75% |
| 2017 Q3 | 55.43 Billion JPY | 113.09% |
| 2017 Q2 | 26.01 Billion JPY | -44.95% |
| 2017 Q1 | 47.25 Billion JPY | 336.28% |
| 2017 FY | 127.87 Billion JPY | -16.99% |
| 2016 Q1 | 49.12 Billion JPY | 237.02% |
| 2016 Q4 | -20 Billion JPY | -137.45% |
| 2016 FY | 154.05 Billion JPY | 107.0% |
| 2016 Q3 | 53.4 Billion JPY | 11.54% |
| 2016 Q2 | 47.88 Billion JPY | -2.54% |
| 2015 FY | 74.42 Billion JPY | -34.09% |
| 2015 Q2 | 27.44 Billion JPY | -16.29% |
| 2015 Q3 | 39.73 Billion JPY | 44.78% |
| 2015 Q4 | -35.85 Billion JPY | -190.22% |
| 2015 Q1 | 32.79 Billion JPY | 185.83% |
| 2014 Q3 | 52.6 Billion JPY | 40.27% |
| 2014 Q1 | 15.18 Billion JPY | 117.6% |
| 2014 FY | 112.92 Billion JPY | 14.36% |
| 2014 Q4 | 11.47 Billion JPY | -78.19% |
| 2014 Q2 | 37.5 Billion JPY | 147.04% |
| 2013 Q2 | 24.55 Billion JPY | -24.49% |
| 2013 Q4 | 6.97 Billion JPY | -80.87% |
| 2013 FY | 98.74 Billion JPY | 0.55% |
| 2013 Q1 | 32.52 Billion JPY | 413.74% |
| 2013 Q3 | 36.46 Billion JPY | 48.49% |
| 2012 FY | 98.2 Billion JPY | -19.6% |
| 2012 Q1 | 43.48 Billion JPY | 2775.79% |
| 2012 Q2 | 18.71 Billion JPY | -56.97% |
| 2012 Q3 | 29.68 Billion JPY | 58.63% |
| 2012 Q4 | 6.33 Billion JPY | -78.67% |
| 2011 Q3 | 30.52 Billion JPY | 5.09% |
| 2011 FY | 122.14 Billion JPY | 27.89% |
| 2011 Q4 | 1.51 Billion JPY | -95.05% |
| 2011 Q2 | 29.04 Billion JPY | -52.43% |
| 2011 Q1 | 61.06 Billion JPY | 1020.8% |
| 2010 Q2 | 24.08 Billion JPY | -10.02% |
| 2010 Q3 | 39.21 Billion JPY | 62.82% |
| 2010 Q4 | 5.44 Billion JPY | -86.11% |
| 2010 FY | 95.5 Billion JPY | 7.47% |
| 2010 Q1 | 26.76 Billion JPY | 391.47% |
| 2009 Q2 | 21.61 Billion JPY | 0.0% |
| 2009 Q3 | 36.44 Billion JPY | 68.63% |
| 2009 Q4 | -9.18 Billion JPY | -125.2% |
| 2009 FY | 88.87 Billion JPY | -43.33% |
| 2008 FY | 156.82 Billion JPY | 15.05% |
| 2007 FY | 136.31 Billion JPY | -11.9% |
| 2006 FY | 154.72 Billion JPY | 82.19% |
| 2005 FY | 84.92 Billion JPY | -11.12% |
| 2004 FY | 95.55 Billion JPY | 19.69% |
| 2003 FY | 79.83 Billion JPY | -1.01% |
| 2002 FY | 80.64 Billion JPY | -8.13% |
| 2001 FY | 87.78 Billion JPY | -38.48% |
| 2000 FY | 142.71 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AstraZeneca PLC | 8.19 Billion USD | -2482.546% |
| Bristol-Myers Squibb Company PFD CONV 2 | 17.24 Billion USD | -1127.166% |
| CSPC Pharmaceutical Group Limited | 7.01 Billion USD | -2915.788% |
| Clarus Therapeutics Holdings, Inc. | -39.73 Million USD | 532638.005% |
| Novartis AG | 9.76 Billion USD | -2065.913% |
| PT Kalbe Farma Tbk. | 3625.13 Billion USD | 94.163% |